30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers

NCT00587496 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

NIH

Sponsor class

Conditions

Herpes Simplex

Interventions

DRUG: valacyclovir hydrochloride
DRUG: placebo
DRUG: valacyclovir plus aspirin

Sponsor

National Eye Institute (NEI)